Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
First Claim
1. A method for treating an alcohol or drug addicted individual exhibiting one or more symptoms of alcohol or drug addiction, wherein the one or more symptoms comprise a lack of protein digestion, a lack of nutrient absorption or a combination thereof;
- the method comprising;
(a) obtaining a fecal sample from the individual;
(b) measuring a level of chymotrypsin present in the fecal sample, wherein measuring comprises enzymatic photospectrometry analysis;
(c) comparing the level of chymotrypsin present in the fecal sample to a normal level of fecal chymotrypsin;
(d) administering a therapeutically effective amount of digestive enzymes to the individual if the measured fecal level of chymotrypsin is less than the normal level of fecal chymotrypsin;
wherein the digestive enzymes comprise pancreatin, amylases, lipases, proteases or a combination thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
A therapeutic agent for the treatment of the symptoms of addiction and the method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the gastrointestinal tract to determine the presence of symptoms of addiction, and the likelihood of relapsing into addiction is disclosed.
191 Citations
13 Claims
-
1. A method for treating an alcohol or drug addicted individual exhibiting one or more symptoms of alcohol or drug addiction, wherein the one or more symptoms comprise a lack of protein digestion, a lack of nutrient absorption or a combination thereof;
- the method comprising;
(a) obtaining a fecal sample from the individual; (b) measuring a level of chymotrypsin present in the fecal sample, wherein measuring comprises enzymatic photospectrometry analysis; (c) comparing the level of chymotrypsin present in the fecal sample to a normal level of fecal chymotrypsin; (d) administering a therapeutically effective amount of digestive enzymes to the individual if the measured fecal level of chymotrypsin is less than the normal level of fecal chymotrypsin;
wherein the digestive enzymes comprise pancreatin, amylases, lipases, proteases or a combination thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
- the method comprising;
Specification